Literature DB >> 30166342

Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.

Ah-Mee Park1, Ikuo Tsunoda2, Osamu Yoshie2,3.   

Abstract

Heat shock protein 27 (HSP27) protects cells under stress. Here, we demonstrate that HSP27 also promotes cell cycle progression of MRC-5 human lung fibroblast cells. Serum starvation for 24 h induced G1 arrest in these cells, and upon serum refeeding, the cells initiated cell cycle progression accompanied by an increase in HSP27 protein levels. HSP27 levels peaked at 12 h, and transcriptional up-regulation of six G2/M-related genes (CCNA2, CCNB1, CCNB2, CDC25C, CDCA3, and CDK1) peaked at 24-48 h. siRNA-mediated HSP27 silencing in proliferating MRC-5 cells induced G2 arrest coinciding with down-regulation of these six genes. Of note, the promoters of all of these genes have the cell cycle-dependent element and/or the cell cycle gene-homology region. These promoter regions are known to be bound by the E2F family proteins (E2F-1 to E2F-8) and retinoblastoma (RB) family proteins (RB1, p107, and p130), among which E2F-4 and p130 were strongly up-regulated in HSP27-knockdown cells. E2F-4 or p130 knockdown concomitant with the HSP27 knockdown rescued MRC-5 cells from G2 arrest and up-regulated the six cell cycle genes. Moreover, we observed cellular senescence in MRC-5 cells on day 3 after the HSP27 knockdown, as evidenced by increased senescence-associated β-gal activity and up-regulated inflammatory cytokines. The cellular senescence was also suppressed by the concomitant knockdown of E2F-4/HSP27 or p130/HSP27. Our findings indicate that HSP27 promotes cell cycle progression of MRC-5 cells by suppressing expression of the transcriptional repressors E2F-4 and p130.
© 2018 Park et al.

Entities:  

Keywords:  E2F transcription factor; HSPB1; cell cycle; cell proliferation; cellular senescence; cyclin A2; cyclin B1; cyclin B2; small heat shock protein (sHsp); transcription repressor

Mesh:

Substances:

Year:  2018        PMID: 30166342      PMCID: PMC6187643          DOI: 10.1074/jbc.RA118.003310

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Heat-shock proteins reverse the G2 arrest caused by HIV-1 viral protein R.

Authors:  Michael Bukrinsky; Yuqi Zhao
Journal:  DNA Cell Biol       Date:  2004-04       Impact factor: 3.311

Review 2.  Aging, cellular senescence, and cancer.

Authors:  Judith Campisi
Journal:  Annu Rev Physiol       Date:  2012-11-08       Impact factor: 19.318

Review 3.  The cell fate: senescence or quiescence.

Authors:  Menderes Yusuf Terzi; Muzeyyen Izmirli; Bulent Gogebakan
Journal:  Mol Biol Rep       Date:  2016-08-24       Impact factor: 2.316

Review 4.  The cell cycle and cancer.

Authors:  Gareth H Williams; Kai Stoeber
Journal:  J Pathol       Date:  2011-10-28       Impact factor: 7.996

Review 5.  The cell cycle: a review.

Authors:  K A Schafer
Journal:  Vet Pathol       Date:  1998-11       Impact factor: 2.221

6.  Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection.

Authors:  Meyer J Friedman; Shihua Li; Xiao-Jiang Li
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

Review 7.  Hsp27 as a therapeutic target in cancers.

Authors:  Julie Acunzo; Claudia Andrieu; Virginie Baylot; Alan So; Palma Rocchi
Journal:  Curr Drug Targets       Date:  2014-04       Impact factor: 3.465

Review 8.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

9.  Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Ah-Mee Park; Kyosuke Kanai; Tatsuki Itoh; Takao Sato; Tatsuya Tsukui; Yutaka Inagaki; Moises Selman; Kouji Matsushima; Osamu Yoshie
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

10.  Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression.

Authors:  Arne Lindqvist; Wouter van Zon; Christina Karlsson Rosenthal; Rob M F Wolthuis
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

View more
  5 in total

1.  Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.

Authors:  Khanh T Do; Geraldine O'Sullivan Coyne; John L Hays; Jeffrey G Supko; Stephen V Liu; Kristin Beebe; Len Neckers; Jane B Trepel; Min-Jung Lee; Tomoko Smyth; Courtney Gannon; Jennifer Hedglin; Alona Muzikansky; Susana Campos; John Lyons; Percy Ivy; James H Doroshow; Alice P Chen; Geoffrey I Shapiro
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-23       Impact factor: 3.333

2.  Oral Soft Tissue Regeneration Using Nano Controlled System Inducing Sequential Release of Trichloroacetic Acid and Epidermal Growth Factor.

Authors:  Kwang Man Park; Hong Jae Lee; Ki-Tae Koo; Heithem Ben Amara; Richard Leesungbok; Kwantae Noh; Sang Cheon Lee; Suk Won Lee
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

3.  Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia.

Authors:  James N Fisher; Angeliki Thanasopoulou; Sabine Juge; Alexandar Tzankov; Frederik O Bagger; Max A Mendez; Antoine H F M Peters; Juerg Schwaller
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

Review 4.  Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond.

Authors:  Benjamin J Lang; Martín Eduardo Guerrero-Giménez; Thomas L Prince; Andrew Ackerman; Cristina Bonorino; Stuart K Calderwood
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

Review 5.  Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.

Authors:  Morgane Lallier; Louise Marchandet; Brice Moukengue; Celine Charrier; Marc Baud'huin; Franck Verrecchia; Benjamin Ory; François Lamoureux
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.